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Abstract
Background: Mortality from acute complications of diabetes, a predominantly preventable condition, although
controlled in high income countries, remains a major challenge for low/middle income countries. The aim of this
study is to describe trends in mortality from acute complications of diabetes between 1991 and 2010 in Brazil, a
period during which a national health system was implemented offering broad access to diabetes treatment.
Methods: We obtained the number of deaths listed in the Brazilian Mortality Information System between 1991
and 2010 as due to acute complications of diabetes (ICD-9 250.1, .2, or .3 and ICD-10 E10–14.0 or 1), corrected this
number for ill-defined causes of death and incompleteness in mortality reporting, and calculated mortality rates
standardized to the world’s population. We describe mortality trends with Joinpoint regressions.
Results: Over this 20 year period, mortality due to the acute complications of diabetes fell 70.9 % (95 % CI 67.2 to
74.5 %), from 8.42 (95 % CI 8.27 to 8.57) deaths per 100000 inhabitants in 1991 to 2.45 (95 % CI 2.38 to 2.52) per
100000 in 2010. The reduction occurred in men and women, in all age groups, and in all regions of Brazil.
Conclusions: Mortality from acute complications of diabetes in Brazil has declined markedly in parallel with the
implementation of a national health system providing access to insulin and organization of health care. Further
decline is possible and necessary.
Background
The United Nations and the World Health Organization
(WHO) have emphasized the vital importance of preven-
tion and control of the non-communicable diseases
(NCDs) in low- and middle-income countries [1], elect-
ing to focus actions on four groups of diseases: cardio-
vascular diseases, cancer, chronic respiratory diseases,
and diabetes.
Diabetes mellitus is now estimated to be the fifth
underlying cause of mortality globally [2], thus establish-
ing itself as a significant and growing global health issue.
Effective approaches to confronting diabetes and the
other main NCDs in the midst of the current obesity
epidemic have been widely debated, and the importance
of strong national health systems has been recently em-
phasized [3, 4].
Brazil, a middle-income country with 200 million in-
habitants, is striving to confront the increased burden of
the NCDs. Diabetes is a major part of that burden, as
Brazil is listed by the International Diabetes Federation
has having the 4th largest number of people with dia-
betes in the world [5]. Prevalence among adults, most
recently estimated by self-report at 6.2 % [6], may well
be double that, given incomplete assessment [7], and has
grown 25 % between 2006 and 2013 [8].
Much progress has been achieved in the care of those
with diabetes over the past two decades. In 1988 a na-
tional health system (Sistema Único de Saúde, SUS)
which provides free and comprehensive care without
user fees, and aims for universal access and reduction of
health inequities was implemented [9]. Evaluation of
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trends during this period in relevant outcomes related to
diabetes has rarely been done. In this regard, the preven-
tion of death from acute complications of diabetes is of
major importance now to low/middle income countries,
since, in principle, these deaths are almost entirely pre-
ventable (especially before age 40) [10]. High income
countries have made great progress in this regard [11–13],
but this task remains a major challenge for low and mid-
dle income countries. Furthermore, the relative simplicity
of monitoring these deaths provides an important yard-
stick for gauging the results of actions to prevent and con-
trol diabetes.
Within this context, the aim of this study is to evaluate
trends in mortality in Brazil due to the acute complica-
tions of diabetes (diabetic ketoacidosis, hyperosmolar
hyperglycemic state, and hypoglycemia), starting from
1991, shortly after Brazil’s national health system was
implemented, and covering a period during which health
care for diabetes has been progressively organized. Given
that acute complication deaths are relatively more fre-
quent prior to age 40, are more preventable, and con-
tribute importantly to the disease’s burden [14–16], we
also investigated trends in deaths prior to age 40.
Materials and methods
We employed secondary data to characterize national
trends in mortality. We downloaded public domain demo-
graphic data available from the Brazilian Institute of Geog-
raphy and Statistics (IBGE) and mortality data reported
through Brazil’s Mortality Information System (SIM) for
the years 1991 to 2010 [17]. Death from diabetes was de-
fined by one of the following three-character codes of the
International Statistical Classification of Diseases and
Related Health Problems, 9th Revision (ICD-9): “250”
(Diabetes mellitus) or 10th Revision (ICD-10): “E10” (Insu-
lin-dependent diabetes mellitus), “E11” (Non-insulin-
dependent diabetes mellitus), “E12” (Malnutrition-related
diabetes mellitus), “E13” (Other specified diabetes mellitus),
or “E14” (Unspecified diabetes mellitus). A death due to an
acute complication of diabetes was defined as any death
listing the above codes and also presenting the fourth-
character subdivision “.1” (with ketoacidosis), “.2” (with
hyperosmolarity), or “.3” (with other coma) in ICD-9 or
“.0” (Coma with or without ketoacidosis, hyperosmolar
coma, hypoglycemic coma, or hyperglycemic coma
NOS) or “.1” (Ketoacidosis or acidosis without mention
of coma) in ICD-10. We investigated mortality over the
complete age range, and also before 40 years of age. The
literature suggests that acute causes are relatively more
frequent among diabetes deaths prior to age 40, are more
preventable, and given the greater number of years of life
lost with each death, contribute importantly to the dis-
ease’s burden [14–16].
We used IBGE census (1991, 2000, 2010), IBGE popu-
lation count (1996), or linear interpolation between the
above-listed years to determine population size. The
study period was confined to the years 1991 to 2010, as
the former year was the first for which data necessary
for determining completeness of death reporting were
available, and the latter was the last for which mortality
data were available.
Brazilian mortality registration has made steady process
in completeness of reporting (estimated completeness –
1991: 77.6 %, 2011: 94.2 %): and definition of the cause of
death (ill-defined deaths – 1991: 18.2 %, 2010: 6.7 %) over
the past two decades [18–20]. In trend analyses, correc-
tions must be made in order to take greater past lack of
completeness (deaths not notified) and more frequent
ill-defined causes into account. Using an approach
similar to that taken in key analyses of the Ministry of
Health [21, 22], we corrected reported deaths for both
estimated lack of completeness of death registration
and for ill-defined causes of death (chapter XVI of
ICD-9, “Signs, symptoms and ill-defined conditions”
(codes 780–799), and chapter XVIII of the ICD-10,
“Symptoms, signs and abnormal clinical and laboratory
findings, not elsewhere classified” (codes R00-R99).).
The approach to these corrections has evolved over the
years. We based correction for lack of completeness for
1991 on the estimated number of deaths furnished by
IBGE, and calculated correction factors separately for
each gender/age group/region strata. We corrected lack
of completeness for the years 2000 to 2010 based on a
study of active investigation of undeclared deaths [23]
and performed the correction separately for each feder-
ative unit. Whenever the number of estimated deaths,
after correction, was higher than that reported, we used
the ratio of estimated to reported deaths as a correction
factor. We applied linear interpolation of the data of 1991
and 2000 to estimate lack of completeness of death regis-
tration for the years 1992–1999. We corrected ill-defined
causes of death by redistributing these deaths under the
assumption that their distribution followed that of re-
ported non-external cause deaths [24, 25].
We calculated the mortality rate for acute complica-
tions of diabetes annually. Given relatively small absolute
numbers of deaths due to acute complications among
those under 40 years of age in the north, center-west, and
south regions of Brazil, the means of the annual mortality
rate within the periods 1991–1995 and 2006–2010 were
used to show trends for these groups. We tested statistical
significance in the comparison between the two rates
using either the confidence intervals of the rate ratios [26]
or the p-value of the z-score for the difference between
rates [27], the significance level being set at 0.05.
To facilitate comparisons between countries and
across regions within Brazil, we directly standardized
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mortality rates by age and sex to the world standard
population [24, 28]. In these analyses, age was stratified
in intervals of 5 years up to 79 (0–4 years, 5–9, 10–14,
15–19, 20–24, 25–29, 30–34, 35–39, 40–44, 45–49, 50–
54, 55–59, 60–64, 65–69, 70–74, 75–79), the final strata
being 80 years and older. We performed calculations
with Stata 10.0. We analyzed trends in mortality from
acute complications during the period with the Joinpoint
Regression Program, starting with a maximum of 3 join-
points and using the permutation method to determine
the best model fit [29]. Though these numbers represent
the universe, and as such do not require confidence in-
tervals, we have included these intervals at times.
The project (number 100056) was approved by the
Ethics Committee of Hospital de Clínicas de Porto Ale-
gre. As analyses were based on surveillance databases
from the Ministry of Health, no patient consent was
necessary.
Results
Over the 1991–2010 period, 694769 deaths occurred
due to diabetes in Brazil, of which 81208 (11.7 %) were
due to acute complications. Eighty-eight percent of
deaths from acute complications coded by ICD-10 did
not specify the type of diabetes (coding E14 - unspeci-
fied), and type of diabetes was also not obtainable from
the data coded under ICD-9 (less than 30 % of the
deaths from acute complications in the period were
coded according to ICD-9). With regard to the type of
acute complication, from 1991 to 1995 (ICD-9), 11274
(44.6 %) deaths were due to ketoacidosis, 7593 (30.0 %)
to hyperosmolarity and 6414 (25.4 %) to other coma;
from 1996 onward (ICD-10), 26544 deaths (47.5 %) were
due to coma and 29383 (52.5 %) to ketoacidosis or acid-
osis without coma.
Table 1 shows a progressive reduction in the number
of deaths from acute complications in men and women
over time. The reduction is more pronounced when
examining the age-adjusted mortality rates. In 1991, the
mortality rate was 26 % higher in women than in men.
The ratio of mortality rates between the sexes decreased
progressively over time, being only 5 % higher in women
by 2010.
Figure 1 illustrates rates of mortality due to the acute
complications of diabetes in Brazil from 1991 to 2010.
Panel a shows a reduction of 70.9 % (95 % CI 67.2 to
Table 1 Mortality rates due to the acute complications of diabetes in Brazil, 1991 to 2010a
Year Men Women Female/
male ratiobDeaths Mortality rate (95 % CI) Deaths Mortality rate (95 % CI)
1991 2070 7.45 (7.25-7.65) 2832 9.36 (9.14-9.58) 1.26
1992 1917 6.50 (6.32-6.69) 2868 9.05 (8.84-9.27) 1.39
1993 2025 6.64 (6.46-6.83) 2845 8.66 (8.45-8.87) 1.30
1994 2117 6.54 (6.36-6.72) 2944 8.07 (7.87-8.27) 1.23
1995 2323 6.96 (6.78-7.15) 3138 8.25 (8.05-8.45) 1.18
1996 1780 5.34 (5.18-5.50) 2576 7.00 (6.82-7.19) 1.31
1997 1724 5.03 (4.87-5.19) 2433 6.19 (6.02-6.36) 1.23
1998 1558 4.14 (4.00-4.28) 2253 5.20 (5.05-5.36) 1.26
1999 1601 4.14 (4.00-4.28) 2260 5.00 (4.85-5.15) 1.21
2000 1667 4.05 (3.91-4.18) 2239 4.56 (4.42-4.70) 1.13
2001 1512 3.61 (3.48-3.74) 2110 4.17 (4.03-4.30) 1.15
2002 1486 3.32 (3.20-3.44) 2136 3.93 (3.80-4.06) 1.18
2003 1484 3.16 (3.04-3.28) 1980 3.47 (3.34-3.59) 1.10
2004 1422 2.87 (2.76-2.98) 2047 3.35 (3.23-3.47) 1.17
2005 1498 2.80 (2.69-2.91) 2124 3.24 (3.13-3.36) 1.16
2006 1417 2.48 (2.37-2.58) 1978 2.75 (2.64-2.85) 1.11
2007 1537 2.54 (2.44-2.65) 2032 2.70 (2.60-2.81) 1.06
2008 1572 2.50 (2.40-2.60) 2037 2.58 (2.48-2.68) 1.03
2009 1479 2.28 (2.18-2.38) 2063 2.52 (2.42-2.62) 1.10
2010 1600 2.39 (2.29-2.49) 2141 2.51 (2.41-2.61) 1.05
CI = Confidence interval
afor men and women, /100000 inhabitants, corrected for lack of completeness of death registration and ill-defined causes of death, and standardized to the world
population standard
bStatistically significant (P < 0.001) for all years to 2006 and in 2009, P = 0.027 in 2007 and not statistically significant in 2008 and 2010
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74.5 %) in mortality, from 8.42 (95 % CI 8.27 to 8.57) deaths
per 100000 inhabitants in 1991 to 2.45 (95 % CI 2.38 to
2.52) deaths per 100000 in 2010. This decline has been less
pronounced in recent years.
In 1991, 4902 deaths were due to these complica-
tions, accounting for 26.1 % (95 % CI 25.4 to 26.7 %)
of all deaths with diabetes as the underlying cause,
whereas by 2010, this had declined to 3741 deaths,
corresponding to 6.8 % (95 % CI 6.6–7.0 %) of all
deaths, a reduction of 73.8 % (95 % CI 69.6 to 78.1 %)
in this proportion. Rates of decline produced by Join-
point regression demonstrate that the greatest rate of
decline (a decline of 0.74 deaths/100000 inhabitants/
yr) occurred early in the period, from 1995 to 1998.
Panel b of the same figure shows a reduction of 74.5 %
(95 % CI 63.0 to 86.1 %) in mortality from these
complications in adults under 40 years of age: from 1.15
(95 % CI 1.09 to 1.21) deaths per 100000 in 1991 to 0.29
(95 % CI 0.26 to 0.32) per 100000 in 2010. In 1991, the
646 such deaths that occurred accounted for 53.9 % of all
deaths due to diabetes in this age group, whereas by 2010,
just 313 acute complication deaths occurred, accounting
for only 22.9 % to total deaths due to diabetes, a reduction
of 57.5 % (95 % CI 44.0 to 71.0 %) in this proportion. Join-
point regression again demonstrates a slowing of this de-
cline, the inflexion occurring in 2002.
Panel a of Fig. 2 illustrates that the reduction in mor-
tality occurred in all Brazilian regions (p < 0.001, in all
regions). The decline was somewhat greater in the
Northeast (72.1 %, 95 % CI 66,3-78,0 %), Brazil’s poorest
region, than for Brazil as a whole (70.9 %). As can be
seen in Panel b of this Figure, the decline in mortality in
Fig. 1 Trends in mortality due to the acute complications of diabetes in Brazil, 1991–2010*. Panel (a): All ages. Panel (b): Those less than 40 years
old. *Corrected for lack of completeness of death registration and ill-defined causes of death, and standardized to the World Population Standard
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those under the age of 40 was also observed in all re-
gions of Brazil. Again, the decline was greater in the
Northeast (69.5 %, 95 % CI 66.7-72.3 %) than for Brazil
overall (67.9 %) considering the average reduction be-
tween periods 1991–1995 and 2006–2010.
The decline was observed in all age strata (p = 0.039 in
the under-fives and p < 0.001 in 10 years or more),
though not reaching statistical significance in the range
of five to nine years (p = 0.323), which had the lowest
number of deaths (only nine, in both 1991 and 2010).
Discussion
Mortality due to the acute complications of diabetes in
Brazil showed a major decline between 1991 and 2010.
Standardized mortality fell approximately 71 % (from 8.4
to 2.4 per 100000), and the fraction of such deaths
among those having diabetes as the underlying cause de-
creased from 26.1 % to 6.8 %. The decline occurred in
all regions, in both sexes, and in all age groups, despite
the fact that the prevalence of diabetes in Brazil has in-
creased notably over this period [30, 31].
Declines of similar or larger size have been docu-
mented over the latter half of the 20th Century in high-
income countries, accompanying greater organization of
and increased access to health care. In the United States,
mortality due to hyperglycemic crises declined from 1.53
to 0.75 deaths per 100000 population over the 30 year
period from 1980 to 2009 [11]. When expressed as
deaths per estimated number of persons with diabetes,
fatality due to acute complications fell by 64 % from
1990 to 2010 [32]. In Japan, a study of patients with dia-
betes diagnosed before 18 years of age observed a de-
crease from 421 to 83 deaths from acute complications
per 100000 persons with diabetes per year, from the
period 1965–1970 to that of 1975–1980 [33]. We know
of no studies relating national trends in mortality due to
acute diabetes complications in low and middle income
countries, home of approximately 80 % of the world’s
population affected by diabetes.
Although several factors may have contributed to the
marked changes observed in this risk of dying in the
abovementioned countries, including improvements in
Fig. 2 Trends in mortality due to the acute complications of diabetes in Brazil, 1991–2010, by region*. Panel (a): All ages. Panel (b): Those less than
40 years old. *Corrected for lack of completeness of death registration and ill-defined causes of death, and standardized to the World Population Standard
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the living conditions of individuals and in health services
in general, historical data suggest a critical role for in-
creased access to insulin [34]. Before the availability of
insulin, Type 1 diabetes was highly fatal in the first years
following diagnosis, as illustrated by the experience of
the Joslin Clinic. In the 1897–1914 period, the mortality
rate of diabetic children aged 10 at Joslin was 894 per
1000/year [34]. After the introduction of insulin therapy
in 1922, this annual mortality fell by more than 80 %, to
61.4 per 1000 during the period 1922–1926. By 1939–
1947, following major improvements in availability of in-
sulin and the advent of clinical use of penicillin, mortal-
ity declined further, now by more than 90 %, to 3.3
deaths per 1000. And by the period 1950–1961, mortal-
ity had declined still further, to 1.0 per 1000 [34]. During
the years 1922 to 1929, 14.5 % of deaths were caused by
diabetic coma, whereas by 1956–1962 this proportion
had decreased to 1.0 % [34].
Thus, we believe that the rapid and marked decline
observed in our study resulted, in large part, from simi-
lar advances – increased access to insulin, antibiotics
and qualified care. Given the time frame of our study,
these improvements were largely made possible through
the implementation of Brazil’s national health system.
Prior to its implementation, health care was fragmen-
ted and access limited, with most public coverage of
chronic conditions, other than hypertension, involving
hospital care in major urban areas. The expansion of the
SUS over the past two decades provided access to an
ample range of health care services for the first time to
millions of Brazilians with chronic diseases. Currently,
an estimated 74 % of the population depends on this
public system for their care [35]. The creation of the
Community Health Workers Program in 1991 and its
expansion into the Family Health Program in 1994 initi-
ated a large primary care network, today called the Fam-
ily Health Strategy. From that point to the year 2010,
over 30000 multidisciplinary teams, consisting of a phys-
ician, a nurse, a nurse’s aide and paid community health
workers, were organized to provide health care, each
covering about 1000 families in a pre-defined territory.
Slightly more than 50 % of Brazilians report receiving
their care from these teams [30]. An additional fraction,
especially in large metropolitan areas, receives free, pub-
lic ambulatory care in various specialty clinics.
Prior to 1990, access free of charge to insulin was
quite limited. In the early 1990s the Ministry of Health
produced a National Diabetes Plan, which proposed an
equation to calculate the amount of insulin needed per year
in Brazil for universal coverage and amplified public
purchase of the drug. Throughout the 1990s the restructur-
ing of care for chronic conditions such as hypertension and
diabetes at the primary care level progressed, with in-
creasing free public distribution of low cost anti-
diabetic medications. In 2001, a major program empha-
sizing the universal treatment of these conditions at the
primary care level, the Plan to Reorganize Care of
Hypertension and Diabetes Mellitus [36], was launched.
The National Program of Pharmaceutical Provision for
Hypertension and Diabetes, created in 2002, and subse-
quent laws and regulations, have allowed a progres-
sively larger distribution, free of charge, of medicines
and medical supplies to the entire population with dia-
betes in Brazil [37]. Over this period, the SUS also or-
ganized the treatment of emergencies, equipping
emergency care facilities, providing ambulances, and
organizing hotline call systems [38, 39]. In addition to
further facilitating access to free medications, more re-
cent efforts have focused on promoting a restructuring
of the healthcare system in Brazil, shifting its focus to-
ward the care of chronic conditions [9].
The changes in the rate of the decline within the
period studied deserve further discussion. In the early
1990s, when mortality was highest, inadequate access to
insulin was likely the major determinant of deaths. Subse-
quent greater availability of insulin through the SUS dur-
ing the 1990s may be the main explanation for the sharp
reductions in deaths observed. Over time, with the struc-
turing of distribution systems and purchasing processes,
and a clearer allocation of responsibilities among different
administrative levels of the system, the magnitude of the
problem of availability of insulin, other diabetes medica-
tions, and supplies diminished greatly. Thus additional,
more complex actions, such as the reorganization of care
focusing more on the needs of people with chronic condi-
tions, have likely assumed a greater importance in reduc-
tions in mortality in more recent years.
Of note, despite this progress, mortality from acute
complications of diabetes in Brazil in 2010 was still un-
acceptably high, 3.3 times greater than what recently
reported for the U.S. levels [11]. For those under 40,
Brazil’s 2004 mortality level, approximately 0.39 deaths
per 100000 population, was similar to that observed
between 1968 and 1979 in the state of Washington
[40]. Thus, much room exists for additional improve-
ments: strengthening the links which create networks
between the relevant parts of the health care system –
primary care, emergency care, hospital care, and
pharmaceutical delivery, among others; enhancing co-
ordination of care; increasing access to health services,
including telephone advice for hyper and hypoglycemia
crises [39]; and improving education for physicians and
for patients on the identification and management of
the acute complications of diabetes [39, 41]. When
implemented, these actions need to be tailored so as to
take into account remaining regional health inequities
as well as the social adversities within which many who
have diabetes live.
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Brazil is a country of great inequalities, and its national
health system has established the goal to diminish those
seen in health. At a regional level, the Northeast, the
second largest region in terms of population, is consi-
derably poorer than Brazil as a whole. Traditionally resi-
dents of this region have had less access to health care.
This is reflected in the higher mortality rates seen, in
1991 for this region. As declines, both in terms of rela-
tive and perhaps more importantly absolute terms, were
greater in the Northeast than overall suggests that
progress has been made in reducing health inequalities
related to diabetes.
The higher mortality from acute complications of dia-
betes we found in women has been previously reported
by others [42]. A previous Brazilian study also found
higher mortality due to all complications of diabetes in
women [43]. This differential may merely reflect greater
diagnosis of the disease among women [7], which would
favor the mention of diabetes on their death certificates.
The decrease in the female:male ratio of mortality over
time that we found could thus be explained by the de-
creasing female:male ratio of known diabetes over time.
Given the current stage of both diabetes care and mortal-
ity information systems in many low and middle income
countries, monitoring of deaths from acute complica-
tions of diabetes is a logical indicator to evaluate the
quality of medical care offered to those with diabetes in
these countries [10]. Use of this mortality statistic has
several advantages: comprehensive coverage of the popu-
lation in countries with compulsory registration of deaths;
ability to capture the results of a wide range of actions at
all levels of care; simplicity; easy access to data [17]; and
the possibility of international standardization of results
allowing comparison between countries and over time
[44]. Further, our data show that this indicator offers im-
portant discriminatory power in settings of greater recent
attention to diabetes [44].
Limitations to our analyses deserve mention. Relatively
large fractions of deaths were not registered or had ill-
defined causes over much of the period studied, particu-
larly during the early years. Although these problems
limit the accuracy of our estimates, especially in the ini-
tial years studied [25], we believe that the corrective al-
gorithms we implemented have minimized their impact.
Conclusions
Mortality from acute complications of diabetes in
Brazil has declined markedly over the last two decades
(1991–2010). Though the decline has occurred across
all of Brazil, regional inequalities remain present. The
temporal relationship of this decline with the progressive
implementation of a national health system offering
tax-based universal coverage suggests that the strengths of
this health system made this rapid decline possible.
Specifically, the goal of providing universal access to
health care facilitated diabetes diagnosis and treatment,
especially with regard to the availability of insulin and to
the ready and appropriate management of acute complica-
tions when they present, all of which appears to have con-
tributed to the marked and rapid decline seen.
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